OptimizeRx Acquires RMDY Health

September 5, 2019

OptimizeRx Corporation (NASDAQ: OPRX) agreed to acquire RMDY Health, a digital therapeutics SaaS platform, for $16 million in cash and equity ($8M cash, $8M equity). The deal expands OptimizeRx's patient engagement capabilities into digital therapeutics and adds new client segments including payers, MedTech and medical associations; RMDY will retain its technology team in Tel Aviv while U.S. personnel will operate from OptimizeRx's U.S. offices.

Buyers
OptimizeRx Corporation
Targets
RMDY Health
Sellers
RMDY Health shareholders
Industry
Cloud & SaaS
Location
Israel
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.